No new patients should take Lilly's cancer drug Lartruvo, say regulators - pharmaphorum https://t.co/HH0oLQN4W3 — IDRO (@IDROOhio) January 28, 2019
No new patients should take Lilly's cancer drug Lartruvo, say regulators - pharmaphorum https://t.co/HH0oLQN4W3
No comments:
Post a Comment